首页> 外文期刊>Annals of nuclear medicine >Usefulness of 201TlCl/ 123I-BMIPP dual-myocardial SPECT for patients with non-ST segment elevation myocardial infarction.
【24h】

Usefulness of 201TlCl/ 123I-BMIPP dual-myocardial SPECT for patients with non-ST segment elevation myocardial infarction.

机译:201TlCl / 123I-BMIPP双心肌SPECT对非ST段抬高型心肌梗死患者的有用性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: Earlier studies suggested that elevated cardiac troponin T (cTnT) might be useful for detecting less severe types of myocardial injury (i.e., non-ST segment elevation myocardial infarction). The objective of this study is to elucidate the usefulness of (201)thallous chloride ((201)TlCl) and (123)I-betamethyl-p-iodophenyl-pentadecanoic acid ((123)I-BMIPP) dual-single-photon emission computed tomography (SPECT) imaging for patients with myocardial infarction (MI) without ST segment elevation. METHODS: Consecutive 86 patients (56 men and 30 women; mean age 66 +/- 12 years) clinically diagnosed with acute myocardial infarction (AMI) were divided into two groups according to serum creatine kinase MB (CK-MB) and cTnT levels. Group A consisted of 53 patients with increased serum CK-MB and cTnT levels, and Group B, 33 patients with increased serum cTnT without increased serum CK-MB. All patients underwent (201)TlCl and (123)I-BMIPP dual-SPECT about 8 days following the onset. The left ventricular myocardium was divided into 20 segments on each SPECT image, and tracer accumulation in those segments was scored on a five-point scoring system. The total defect scores (TDS) were calculated by summing the scores for all 20 segments, and compared between groups A and B. Group B patients were subdivided into two groups according to the TDS on (123)I-BMIPP images as groups B(S) (severe; TDS > or = 8) and B(M) (mild; TDS < or = 7), and we compared the prognosis over a period of 2 years from the onset between the three groups. RESULTS: The TDS of group A derived from (201)TlCl and (123)I-BMIPP images was significantly higher than those of group B (14.5 +/- 10.8 vs. 1.5 +/- 2.4 and 20.8 +/- 13.3 vs. 9.1 +/- 6.2, respectively; P < 0.0001). The sensitivities of (201)TlCl and (123)I-BMIPP images were 94.3% (50/53) and 96.2% (51/53) to detect the culprit coronary lesions in group A (no significant difference). In contrast, the sensitivity of (123)I-BMIPP images (72.7%, 24/33) was higher than that of (201)TlCl images (27.3%, 9/33) in group B (P < 0.05). At 2 years of follow-up, the incidence of hard cardiac events in groups A, B(S), and B(M) was 24.5%, 27.8%, and 6.7%, respectively. The rate of group BS, as well as that of group A, was significantly higher than that of group B(M) (P < 0.05). CONCLUSIONS: Of those with a clinical diagnosis of AMI accompanied by increased cTnT, the CK-MB negative patients accounted for 38% (33/86) of all patients as having non-ST segment elevation myocardial infarction such as NTMI. For such patients, (123)I-BMIPP imaging is useful not only for the detection of the culprit lesions but also for the prediction of the prognosis.
机译:目的:较早的研究表明,升高的心肌肌钙蛋白T(cTnT)可能对检测较轻类型的心肌损伤(即非ST段抬高型心肌梗塞)有用。这项研究的目的是阐明(201)氯化亚砜((201)TlCl)和(123)I-β甲基-对碘苯基-十五碳二烯酸((123)I-BMIPP)双单光子发射的有用性无ST段抬高的心肌梗死(MI)患者的计算机X线断层扫描(SPECT)成像。方法:根据血清肌酸激酶MB(CK-MB)和cTnT水平,将86例临床诊断为急性心肌梗死(AMI)的连续患者(56例男性和30例女性,平均年龄66 +/- 12岁)分为两组。 A组由53例血清CK-MB和cTnT水平升高的患者组成,B组由33例血清cTnT升高而血清CK-MB升高的患者组成。所有患者在发病后约8天接受(201)TlCl和(123)I-BMIPP双SPECT。在每个SPECT图像上,将左心室心肌分为20个部分,并在五点评分系统上对这些部分中的示踪剂积累进行评分。通过将所有20个部分的得分相加来计算总缺陷评分(TDS),并在A组和B组之间进行比较。根据(123)I-BMIPP图像上的TDS将B组患者分为两组,即B组( S)(严重; TDS>或= 8)和B(M)(轻度; TDS <或= 7),我们比较了三组患者从发病开始的2年内的预后。结果:从(201)TlCl和(123)I-BMIPP图像得出的A组的TDS显着高于B组(14.5 +/- 10.8对1.5 +/- 2.4对20.8 +/- 13.3对vs.分别为9.1 +/- 6.2; P <0.0001)。 (201)TlCl和(123)I-BMIPP图像检测A组罪犯冠状动脉病变的敏感性分别为94.3%(50/53)和96.2%(51/53)。相比之下,B组的(123)I-BMIPP图像的灵敏度(72.7%,24/33)高于(201)TlCl图像的灵敏度(27.3%,9/33)(P <0.05)。在随访的2年中,A,B(S)和B(M)组的硬性心脏事件发生率分别为24.5%,27.8%和6.7%。 BS组和A组的比率均显着高于B(M)组(P <0.05)。结论:在临床诊断为AMI并伴有cTnT升高的患者中,CK-MB阴性患者占非ST段抬高型心肌梗死(如NTMI)的38%(33/86)。对于此类患者,(123)I-BMIPP成像不仅可用于检测罪魁祸首,而且可用于预测预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号